ciprofloxacin has been researched along with Pregnancy in 85 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Pregnancy: The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Further studies are needed to determine if enrofloxacin administration during late pregnancy potentiates osteochondral alterations in the first year of life." | 9.34 | Administration of enrofloxacin during late pregnancy failed to induce lesions in the resulting newborn foals. ( Canisso, IF; Durgam, S; Ellerbrock, RE; Li, Z; Lima, FS; Litsky, A; Podico, G; Roady, PJ, 2020) |
| " It remains to be determined if enrofloxacin shows toxicity at other stages of pregnancy, after a longer duration of treatment, or once the foals are delivered and articular surfaces are weightbearing." | 9.30 | Diffusion of enrofloxacin to pregnancy fluids and effects on fetal cartilage after intravenous administration to late pregnant mares. ( Canisso, IF; Dirikolu, L; Ellerbrock, RE; Honoroto, J; Lima, FS; Roady, PJ; Rothrock, LT; Wilkins, P; Zhong, L, 2019) |
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 9.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| "We demonstrated no association between miscarriage and maternal ciprofloxacin exposure within the first 22 weeks of pregnancy, or between major malformations and maternal exposure during the first trimester." | 8.12 | Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study. ( Andersen, JT; Gotfredsen, DR; Noergaard, M; Sørensen, AMS, 2022) |
| "Pregnant rabbits were treated with ciprofloxacin alone or with gentamicin in a model of Escherichia coli chorioamnionitis, and the results were compared with those for untreated rabbits." | 7.75 | Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits. ( Caillon, J; Gras-Le Guen, C; Jacqueline, C; Joram, N; Launay, E; Miegeville, AF; Potel, G; Roze, JC, 2009) |
| "To evaluate the immunomodulatory potential of ciprofloxacin in mice with experimental antiphospholipid syndrome (APS)." | 7.70 | Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998) |
| "In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents." | 7.68 | Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993) |
| "Quercetin is a flavonoid with antioxidant properties." | 5.46 | Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin. ( Cetin, A; Demirtas, S; Dogan, Z; Elbe, H; Soysal, H; Taslidere, E, 2017) |
| " Further studies are needed to determine if enrofloxacin administration during late pregnancy potentiates osteochondral alterations in the first year of life." | 5.34 | Administration of enrofloxacin during late pregnancy failed to induce lesions in the resulting newborn foals. ( Canisso, IF; Durgam, S; Ellerbrock, RE; Li, Z; Lima, FS; Litsky, A; Podico, G; Roady, PJ, 2020) |
| " It remains to be determined if enrofloxacin shows toxicity at other stages of pregnancy, after a longer duration of treatment, or once the foals are delivered and articular surfaces are weightbearing." | 5.30 | Diffusion of enrofloxacin to pregnancy fluids and effects on fetal cartilage after intravenous administration to late pregnant mares. ( Canisso, IF; Dirikolu, L; Ellerbrock, RE; Honoroto, J; Lima, FS; Roady, PJ; Rothrock, LT; Wilkins, P; Zhong, L, 2019) |
| "Fifty-three granulocytopenic patients were studied in a randomized trial comparing trimethoprim-sulfamethoxaxole (ST) alone with ST + ciprofloxacin (CPFX) for prevention of bacterial infections." | 5.08 | [Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin]. ( Murase, T, 1995) |
| "We demonstrated no association between miscarriage and maternal ciprofloxacin exposure within the first 22 weeks of pregnancy, or between major malformations and maternal exposure during the first trimester." | 4.12 | Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study. ( Andersen, JT; Gotfredsen, DR; Noergaard, M; Sørensen, AMS, 2022) |
| "To use quantitative magnetic resonance imaging (qMRI), biomechanical testing, and chondrocyte gene expression to evaluate the limbs of foals exposed to enrofloxacin during the third trimester of pregnancy." | 4.02 | Fluoroquinolone exposure in utero did not affect articular cartilage of resulting foals. ( Canisso, IF; Childs, BA; Ellerbrock, RE; Garrett, KS; Herzog, KK; Kersh, ME; Larsen, RJ; Lima, FS; Moshage, SG; Podico, G; Stewart, MC, 2021) |
| " Although ciprofloxacin is very commonly used, safety aspects of maternal treatment during pregnancy are limited, and avoidance of its use during late pregnancy is recommended." | 4.02 | Therapeutic concentration of ciprofloxacin and transfer across the human term placenta. ( Bergholt, T; Jensen, PB; Mathiesen, L; Noergaard, M; Resendal Gotfredsen, D; Trærup Andersen, J, 2021) |
| " Quercetin is a member of flavonoid with strong antioxidant properties, and our results indicate that the use of ciprofloxacin in pregnancy can result damage to fetal brain tissue." | 3.91 | Effects of ciprofloxacin and quercetin on fetal brain development: a biochemical and histopathological study. ( Cetin, A; Dogan, Z; Elibol, E; Turkoz, Y; Vardi, N, 2019) |
| "Ciprofloxacin, ceftriaxone, and sulfamethoxazole/trimethoprim are suitable choices for the treatment of bacterial acute diarrhea." | 3.83 | Characteristics of bacterial acute diarrhea among women. ( Antonello, VS; Dallé, J; Jimenez, MF; Kronbauer, K; Riche, CW; Rocha-Castro, J; Santiago, JA, 2016) |
| " Treatment in indoor locations, presence of urinary catheters and pregnancy along with recent exposure to antibiotics especially fluoroquinolones, third generation cephalosporins and piperacillin-tazobactam were identified as independent risk factors." | 3.83 | Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India. ( Anupurba, S; Banerjee, T, 2016) |
| "Pregnant rabbits were treated with ciprofloxacin alone or with gentamicin in a model of Escherichia coli chorioamnionitis, and the results were compared with those for untreated rabbits." | 3.75 | Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits. ( Caillon, J; Gras-Le Guen, C; Jacqueline, C; Joram, N; Launay, E; Miegeville, AF; Potel, G; Roze, JC, 2009) |
| "The results strongly suggest that Ciprofloxacin, given during pregnancy, causes severe liver damage in foetuses of Wistar albino rats." | 3.72 | Effects of ciprofloxacin on foetal hepatocytes. ( Channa, MA; Janjua, MZ, 2003) |
| "To evaluate the immunomodulatory potential of ciprofloxacin in mice with experimental antiphospholipid syndrome (APS)." | 3.70 | Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression. ( Barak, V; Blank, M; Fishman, P; George, J; Koike, T; Levy, Y; Savion, S; Shoenfeld, Y; Toder, V, 1998) |
| "In recent times there have been several reports of chloramphenicol resistant enteric fever necessitating the use of other antimicrobial agents." | 3.68 | Chloramphenicol resistant enteric fever. ( Chakravorty, B; Gupta, B; Jain, N; Krishna, A; Rajvanshi, P; Sen, MK, 1993) |
| "Ciprofloxacin (CP) was evaluated for bacterial control, post-thaw quality, and fertility of buffalo semen." | 2.78 | Efficiency of ciprofloxacin for bacterial control, post-thaw quality, and in vivo fertility of buffalo spermatozoa. ( Akhter, S; Andrabi, SM; Ansari, MS; Iqbal, R; Qadeer, S; Rakha, BA; Ullah, N, 2013) |
| " As long-term administration of medications is often necessary, the safety of drug therapy during pregnancy and breast-feeding needs to be considered in daily clinical practice." | 2.50 | IBD medications during pregnancy and lactation. ( Hendel, J; Maxwell, C; Nielsen, OH, 2014) |
| "Although scrub typhus is uncommon in pregnant women, when present, it can have serious repercussions for the mother and developing fetus." | 2.43 | Scrub typhus during pregnancy and its treatment: a case series and review of the literature. ( Chang, M; Kim, YS; Lee, HJ; Rhee, YE; Shim, SK; Son, SK, 2006) |
| " This paper reviews the information about the indications, dosage and side effects of Ciprofloxacin and Doxycycline in children and pregnant women and lactating women." | 2.41 | [Tetracyclines and ciprofloxacin as treatment for children and pregnant or lactating women in the era of biological terror]. ( Aizenstien, O; Lehavi, O; Sagi, R, 2002) |
| "The prevalence of genital mycoplasma infections is very high in women with bacterial vaginosis." | 1.72 | Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon. ( Lendamba, RW; Mbeang Nguema, PP; Mombo, LE; Onanga, R, 2022) |
| "Chronic endometritis was found in one-third of infertile women with RIF." | 1.46 | Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure. ( Ishikawa, T; Kitaya, K; Matsubayashi, H; Nishiyama, R; Takaya, Y; Takeuchi, T; Yamaguchi, K, 2017) |
| "Quercetin is a flavonoid with antioxidant properties." | 1.46 | Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin. ( Cetin, A; Demirtas, S; Dogan, Z; Elbe, H; Soysal, H; Taslidere, E, 2017) |
| "Dacryocystitis was surgically drained but relapsed a few weeks later, so it was drained again and a ciprofloksasin-impregnated sponge was placed into the tissue defect that occured after drainage." | 1.39 | Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report. ( Celik, T; Kosker, M; Turkoglu, EB; Yuksel, D, 2013) |
| " Necropsy on day 20 of gestation showed dosage related increase in liver and kidney weights in all rat treated groups." | 1.32 | Developmental toxicity studies of the quinolone antibacterial agent irloxacin in rats and rabbits. ( Demestre, I; García, C; Guzmán, A; Marín, AP; Willoughby, C, 2003) |
| "Guidelines for prophylactic treatment of anthrax and treatment of suspected active cases of anthrax are changing continually, and the Centers for Disease Control and Prevention web site should be consulted for the latest recommendations." | 1.31 | Management of asymptomatic pregnant or lactating women exposed to anthrax. ( , 2002) |
| "Pencillins are not recommended for treatment of anthrax, where such penicillinase activity may decrease their effectiveness." | 1.31 | Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis. ( , 2001) |
| "Oral ciprofloxacin therapy was started on diagnosis, at the 28th week of pregnancy, but symptoms were unabated after 3 weeks treatment, suggesting persisting infection of the products of conception." | 1.30 | Q fever in pregnancy. ( Bishop, NJ; Coomber, S; Cunniffe, J; Ludlam, H; Thomson, BJ; Thornton, S; Wreghitt, TG, 1997) |
| "We report a case of infectious osteitis pubis following a first trimester abortion in a female seropositive for the human immunodeficiency virus (HIV)." | 1.29 | Infectious osteitis pubis in an HIV seropositive female. ( Bignardi, GE; Coker, RJ; Desmond, N; Grech, P; Harris, JR, 1994) |
| " Overall, results indicated (1) no marked differences in pharmacokinetic parameters in pregnant versus nonpregnant females, (2) fleroxacin levels in embryonic tissues were similar to maternal plasma levels, and (3) there was a correlation between exposure and embryolethal doses for all fluoroquinolones which resulted in embryolethality except norfloxacin." | 1.29 | Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis). ( Hendrickx, AG; Hummler, H; Richter, WF, 1993) |
| " The time course of ENR and CIP was fitted by nonlinear least squares regression analysis, and the pharmacokinetic variables were compared." | 1.29 | Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring. ( Abadía, AR; Aramayona, JJ; Bregante, MA; Fraile, LJ; García, MA; Mora, J, 1996) |
| "Ciprofloxacin was also studied for its potential to act as an abortifacient when given orally or parenterally to cynomolgus monkeys." | 1.28 | Ciprofloxacin: toxicologic evaluation of additional safety data. ( Schluter, G, 1989) |
| " Serum and milk samples were obtained simultaneously at two, four, six, nine, 12, and 24 hours after dosage administration." | 1.28 | Pharmacokinetics of three newer quinolones in pregnant and lactating women. ( Aravantinos, D; Gazis, J; Giamarellou, H; Kolokythas, E; Petrikkos, G; Sfikakis, P, 1989) |
| " A good penetration of total radioactivity into tissues and organs with a similar distribution pattern as detected after intravenous dosing also occurred after a single oral administration." | 1.27 | Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats. ( Maruhn, D; Scholl, H; Siefert, HM, 1986) |
| "Ciprofloxacin was absorbed partially (30 to 40%) in both species." | 1.27 | Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys. ( Förster, D; Maruhn, D; Maul, W; Ritter, W; Siefert, HM, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (5.88) | 18.7374 |
| 1990's | 24 (28.24) | 18.2507 |
| 2000's | 24 (28.24) | 29.6817 |
| 2010's | 20 (23.53) | 24.3611 |
| 2020's | 12 (14.12) | 2.80 |
| Authors | Studies |
|---|---|
| Noergaard, M | 2 |
| Gotfredsen, DR | 1 |
| Sørensen, AMS | 1 |
| Andersen, JT | 1 |
| Badawy, S | 1 |
| Yang, Y | 1 |
| Liu, Y | 1 |
| Marawan, MA | 1 |
| Ares, I | 1 |
| Martinez, MA | 1 |
| Martínez-Larrañaga, MR | 1 |
| Wang, X | 1 |
| Anadón, A | 1 |
| Martínez, M | 1 |
| Lendamba, RW | 1 |
| Mbeang Nguema, PP | 1 |
| Onanga, R | 1 |
| Mombo, LE | 1 |
| Natarajan, K | 1 |
| Kasturi, N | 1 |
| Sistla, S | 1 |
| Lin, J | 1 |
| Ding, J | 1 |
| Di, X | 1 |
| Sun, W | 1 |
| Chen, H | 1 |
| Zhang, H | 1 |
| Gu, S | 1 |
| Lai, J | 1 |
| Kang, W | 1 |
| Li, Y | 1 |
| Zhu, X | 1 |
| Ji, T | 1 |
| Feng, J | 1 |
| Zhao, L | 1 |
| Li, Z | 3 |
| Dong, L | 1 |
| Hou, G | 1 |
| Zhu, Y | 1 |
| He, C | 1 |
| Geng, H | 1 |
| Pang, D | 1 |
| Wang, Y | 1 |
| Barnawi, MH | 1 |
| Thabit, AK | 1 |
| Almasri, DM | 1 |
| Bulbol, S | 1 |
| Ellerbrock, RE | 3 |
| Canisso, IF | 3 |
| Larsen, RJ | 1 |
| Garrett, KS | 1 |
| Stewart, MC | 1 |
| Herzog, KK | 1 |
| Kersh, ME | 1 |
| Moshage, SG | 1 |
| Podico, G | 2 |
| Lima, FS | 3 |
| Childs, BA | 1 |
| O'Connor, R | 1 |
| Moloney, GM | 1 |
| Fulling, C | 1 |
| O'Riordan, KJ | 1 |
| Fitzgerald, P | 1 |
| Bastiaanssen, TFS | 1 |
| Schellekens, H | 1 |
| Dinan, TG | 1 |
| Cryan, JF | 1 |
| Ramblière, L | 1 |
| Guillemot, D | 1 |
| Delarocque-Astagneau, E | 1 |
| Huynh, BT | 1 |
| Jensen, PB | 1 |
| Resendal Gotfredsen, D | 1 |
| Bergholt, T | 1 |
| Trærup Andersen, J | 1 |
| Mathiesen, L | 1 |
| Kitaya, K | 1 |
| Matsubayashi, H | 1 |
| Takaya, Y | 1 |
| Nishiyama, R | 1 |
| Yamaguchi, K | 1 |
| Takeuchi, T | 1 |
| Ishikawa, T | 1 |
| Dogan, Z | 2 |
| Elbe, H | 1 |
| Taslidere, E | 1 |
| Soysal, H | 1 |
| Cetin, A | 2 |
| Demirtas, S | 1 |
| Shaharir, SS | 1 |
| Sulaiman Sahari, N | 1 |
| Mohamed Fuad, Z | 1 |
| Zukiman, WZHW | 1 |
| Mohd Yusof, NH | 1 |
| Sulong, A | 1 |
| Periasamy, P | 1 |
| Elibol, E | 1 |
| Vardi, N | 1 |
| Turkoz, Y | 1 |
| Roady, PJ | 2 |
| Rothrock, LT | 1 |
| Zhong, L | 1 |
| Wilkins, P | 1 |
| Dirikolu, L | 1 |
| Honoroto, J | 1 |
| Litsky, A | 1 |
| Durgam, S | 1 |
| Celik, T | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Turkoglu, EB | 1 |
| Akhter, S | 1 |
| Ansari, MS | 1 |
| Rakha, BA | 1 |
| Andrabi, SM | 1 |
| Qadeer, S | 1 |
| Iqbal, R | 1 |
| Ullah, N | 1 |
| Nielsen, OH | 1 |
| Maxwell, C | 1 |
| Hendel, J | 1 |
| Virok, DP | 1 |
| Ábrók, M | 1 |
| Szél, B | 1 |
| Tajti, Z | 1 |
| Mader, K | 1 |
| Urbán, E | 1 |
| Tálosi, G | 1 |
| Melkumyan, AR | 1 |
| Priputnevich, TV | 1 |
| Ankirskaya, AS | 1 |
| Murav'eva, VV | 1 |
| Lubasovskaya, LA | 1 |
| Spellberg, B | 1 |
| Doi, Y | 1 |
| Gurnee, EA | 1 |
| Ndao, IM | 1 |
| Johnson, JR | 1 |
| Johnston, BD | 1 |
| Gonzalez, MD | 1 |
| Burnham, CA | 1 |
| Hall-Moore, CM | 1 |
| McGhee, JE | 1 |
| Mellmann, A | 1 |
| Warner, BB | 1 |
| Tarr, PI | 1 |
| Cardines, R | 1 |
| Daprai, L | 1 |
| Giufrè, M | 1 |
| Torresani, E | 1 |
| Garlaschi, ML | 1 |
| Cerquetti, M | 1 |
| Kaplan, YC | 1 |
| Koren, G | 3 |
| Soni, DK | 1 |
| Singh, DV | 1 |
| Dubey, SK | 1 |
| Rocha-Castro, J | 1 |
| Kronbauer, K | 1 |
| Dallé, J | 1 |
| Jimenez, MF | 1 |
| Riche, CW | 1 |
| Santiago, JA | 1 |
| Antonello, VS | 1 |
| McMahan, DA | 1 |
| Pitcher, ED | 1 |
| Waldron, MR | 1 |
| Billman, AS | 1 |
| Richards, SM | 1 |
| Pontones, PR | 1 |
| Duwve, JM | 1 |
| Allen, KC | 1 |
| Hendricks, K | 1 |
| Sergienko, E | 1 |
| Mirza, R | 1 |
| Chitale, RA | 1 |
| Banerjee, T | 1 |
| Anupurba, S | 1 |
| Martín, MC | 1 |
| Pérez, F | 1 |
| Moreno, A | 1 |
| Moral, A | 1 |
| Alvarez, MA | 1 |
| Méndez, FJ | 1 |
| Vázquez, F | 1 |
| Launay, E | 1 |
| Joram, N | 1 |
| Jacqueline, C | 1 |
| Miegeville, AF | 1 |
| Caillon, J | 1 |
| Potel, G | 1 |
| Roze, JC | 1 |
| Gras-Le Guen, C | 1 |
| Cooper, WO | 1 |
| Hernandez-Diaz, S | 1 |
| Arbogast, PG | 1 |
| Dudley, JA | 1 |
| Dyer, SM | 1 |
| Gideon, PS | 1 |
| Hall, KS | 1 |
| Kaltenbach, LA | 1 |
| Ray, WA | 1 |
| Arredondo-García, JL | 1 |
| Amábile-Cuevas, CF | 1 |
| Lim, SK | 1 |
| Park, IW | 1 |
| Lee, WG | 1 |
| Kim, HK | 1 |
| Choi, YH | 1 |
| Aizenstien, O | 1 |
| Lehavi, O | 2 |
| Sagi, R | 1 |
| Reunala, T | 1 |
| Hiltunen-Back, E | 1 |
| Bossi, P | 1 |
| Bricaire, F | 1 |
| Guzmán, A | 1 |
| García, C | 1 |
| Marín, AP | 1 |
| Willoughby, C | 1 |
| Demestre, I | 1 |
| Smolyakov, R | 1 |
| Talalay, B | 1 |
| Yanai-Inbar, I | 1 |
| Pak, I | 1 |
| Alkan, M | 1 |
| Channa, MA | 1 |
| Janjua, MZ | 1 |
| Yaris, F | 1 |
| Kesim, M | 1 |
| Kadioglu, M | 1 |
| Kul, S | 1 |
| Dignass, AU | 1 |
| Herrlinger, K | 1 |
| Schölmerich, J | 1 |
| Polachek, H | 1 |
| Holcberg, G | 1 |
| Sapir, G | 1 |
| Tsadkin-Tamir, M | 1 |
| Polachek, J | 1 |
| Katz, M | 1 |
| Ben-Zvi, Z | 1 |
| Gerenutti, M | 1 |
| Del Fiol, FS | 1 |
| Groppo, FC | 1 |
| Gürbay, A | 1 |
| Gonthier, B | 1 |
| Barret, L | 1 |
| Favier, A | 1 |
| Hincal, F | 1 |
| Kim, YS | 1 |
| Lee, HJ | 1 |
| Chang, M | 1 |
| Son, SK | 1 |
| Rhee, YE | 1 |
| Shim, SK | 1 |
| Mavrogianni, VS | 1 |
| Amiridis, GS | 1 |
| Gougoulis, DA | 1 |
| Fragkou, IA | 1 |
| Fthenakis, GC | 1 |
| Charles, P | 1 |
| Stumpf, P | 1 |
| Buffet, P | 1 |
| Hot, A | 1 |
| Lecuit, M | 1 |
| Dupont, B | 1 |
| Lortholary, O | 1 |
| Consigny, PH | 1 |
| Koul, PA | 1 |
| Wani, JI | 1 |
| Wahid, A | 1 |
| Leung, D | 1 |
| Venkatesan, P | 1 |
| Boswell, T | 1 |
| Innes, JA | 1 |
| Wood, MJ | 1 |
| Murase, T | 1 |
| Aramayona, JJ | 2 |
| Garcia, MA | 2 |
| Fraile, LJ | 2 |
| Abadía, AR | 2 |
| Bregante, MA | 2 |
| Cuevas, LE | 1 |
| Kazembe, P | 1 |
| Mughogho, GK | 1 |
| Tillotson, GS | 1 |
| Hart, CA | 1 |
| Berkovitch, M | 1 |
| Pastuszak, A | 1 |
| Gazarian, M | 1 |
| Lewis, M | 1 |
| Desmond, N | 1 |
| Bignardi, GE | 1 |
| Coker, RJ | 1 |
| Grech, P | 1 |
| Harris, JR | 1 |
| Hummler, H | 1 |
| Richter, WF | 1 |
| Hendrickx, AG | 1 |
| Chakravorty, B | 1 |
| Jain, N | 1 |
| Gupta, B | 1 |
| Rajvanshi, P | 1 |
| Sen, MK | 1 |
| Krishna, A | 1 |
| Linseman, DA | 1 |
| Hampton, LA | 1 |
| Branstetter, DG | 1 |
| Mora, J | 1 |
| Wilton, LV | 1 |
| Pearce, GL | 1 |
| Mann, RD | 1 |
| Cohen, RO | 1 |
| Colodner, R | 1 |
| Ziv, G | 1 |
| Keness, J | 1 |
| Ludlam, H | 1 |
| Wreghitt, TG | 1 |
| Thornton, S | 1 |
| Thomson, BJ | 1 |
| Bishop, NJ | 1 |
| Coomber, S | 1 |
| Cunniffe, J | 1 |
| Aizenstein, O | 1 |
| Tur-Kaspa, I | 1 |
| James, AH | 1 |
| Katz, VL | 1 |
| Dotters, DJ | 1 |
| Rogers, RG | 1 |
| Blank, M | 1 |
| George, J | 1 |
| Fishman, P | 1 |
| Levy, Y | 1 |
| Toder, V | 1 |
| Savion, S | 1 |
| Barak, V | 1 |
| Koike, T | 1 |
| Shoenfeld, Y | 1 |
| Gupta, D | 1 |
| Sinha, R | 1 |
| Gach, O | 1 |
| Corhay, JL | 1 |
| Lousberg, L | 1 |
| Bartsch, P | 1 |
| Celia, F | 1 |
| Schluter, G | 1 |
| Giamarellou, H | 1 |
| Kolokythas, E | 1 |
| Petrikkos, G | 1 |
| Gazis, J | 1 |
| Aravantinos, D | 1 |
| Sfikakis, P | 1 |
| Ying, LS | 1 |
| Johnson, CA | 1 |
| Siefert, HM | 2 |
| Maruhn, D | 2 |
| Scholl, H | 1 |
| Maul, W | 1 |
| Förster, D | 1 |
| Ritter, W | 1 |
13 reviews available for ciprofloxacin and Pregnancy
| Article | Year |
|---|---|
Toxicity induced by ciprofloxacin and enrofloxacin: oxidative stress and metabolism.
Topics: Aged; Animals; Anti-Infective Agents; Child; Ciprofloxacin; Enrofloxacin; Female; Fluoroquinolones; | 2021 |
Impact of mass and systematic antibiotic administration on antibiotic resistance in low- and middle-income countries? A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Ciprofloxacin; Developing | 2021 |
IBD medications during pregnancy and lactation.
Topics: Ciprofloxacin; Female; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Lactation; Mesalamine; | 2014 |
Use of ciprofloxacin during breastfeeding.
Topics: Adult; Animals; Bone Development; Breast Feeding; Child Development; Ciprofloxacin; Female; Fluoroqu | 2015 |
[Tetracyclines and ciprofloxacin as treatment for children and pregnant or lactating women in the era of biological terror].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bioterrorism; Centers for Disease Control and Preventi | 2002 |
[Changing epidemiological profile and treatment of syphilis and gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Contact Tracing; Drug Resistance, | 2002 |
[Anthrax in the era of biowarfare].
Topics: Adult; Amoxicillin; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Biological Warfare; Biote | 2003 |
Enterobius vermicularis infection of female genital tract: a report of three cases and review of literature.
Topics: Abdominal Pain; Adult; Ciprofloxacin; Enterobiasis; Fallopian Tube Diseases; Fallopian Tubes; Female | 2003 |
Scrub typhus during pregnancy and its treatment: a case series and review of the literature.
Topics: Adult; Ciprofloxacin; Contraindications; Female; Humans; Pregnancy; Pregnancy Complications, Infecti | 2006 |
Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
Topics: Adolescent; Adult; Bacterial Vaccines; Canada; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; | 1994 |
[Ciprofloxacin treatment for pregnant or lactating women and children?].
Topics: Anti-Infective Agents; Child; Ciprofloxacin; Female; Humans; Lactation; Milk, Human; Pregnancy; Preg | 1997 |
Management of placenta accreta with oral methotrexate.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Disease-Free Survival; Endosonogr | 1998 |
Cutaneous anthrax: an overview.
Topics: Adult; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Bacillus anthracis; Bioterrorism; Chil | 2002 |
6 trials available for ciprofloxacin and Pregnancy
| Article | Year |
|---|---|
Diffusion of enrofloxacin to pregnancy fluids and effects on fetal cartilage after intravenous administration to late pregnant mares.
Topics: Abortion, Veterinary; Animals; Anti-Bacterial Agents; Body Fluids; Cartilage; Ciprofloxacin; Enroflo | 2019 |
Administration of enrofloxacin during late pregnancy failed to induce lesions in the resulting newborn foals.
Topics: Animals; Animals, Newborn; Anti-Bacterial Agents; Biomechanical Phenomena; Ciprofloxacin; Dose-Respo | 2020 |
Efficiency of ciprofloxacin for bacterial control, post-thaw quality, and in vivo fertility of buffalo spermatozoa.
Topics: Animals; Anti-Bacterial Agents; Buffaloes; Ciprofloxacin; Cryopreservation; Cryoprotective Agents; F | 2013 |
[Chemoprophylaxis of bacterial infections in granulocytopenic patients with new quinolone: a comparison of trimethoprim-sulfamethoxazole (ST) alone with ST plus ciprofloxacin].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infect | 1995 |
Eradication of nasopharyngeal carriage of Neisseria meningitidis in children and adults in rural Africa: a comparison of ciprofloxacin and rifampicin.
Topics: Adolescent; Adult; Carrier State; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Female; Human | 1995 |
Safety of the new quinolones in pregnancy.
Topics: Abnormalities, Drug-Induced; Adult; Ciprofloxacin; Female; Humans; Infant, Newborn; Musculoskeletal | 1994 |
66 other studies available for ciprofloxacin and Pregnancy
| Article | Year |
|---|---|
Ciprofloxacin exposure and adverse pregnancy outcomes: A Danish nationwide cohort study.
Topics: Abortion, Spontaneous; Ciprofloxacin; Cohort Studies; Denmark; Female; Humans; Pregnancy; Pregnancy | 2022 |
Determination of the prevalence of Mycoplasma hominis and Ureaplasma species in Bacterial vaginosis patients in association with antibiotic resistance profile in Franceville, Gabon.
Topics: Anti-Bacterial Agents; Azithromycin; Child; Ciprofloxacin; Coinfection; Drug Resistance, Microbial; | 2022 |
Assessment of Perinatal Clinical Characteristics, Perinatal Risk Factors, and Microbial Profile in Congenital Nasolacrimal Duct Obstruction in a Tertiary Care Center: A Descriptive Study.
Topics: Cesarean Section; Child; Child, Preschool; Ciprofloxacin; Dacryocystorhinostomy; Eye Abnormalities; | 2022 |
Association between prenatal antibiotics exposure and measures of fetal growth: A repeated-measure study.
Topics: Anti-Bacterial Agents; Birth Weight; Ciprofloxacin; Female; Fetal Development; Humans; Infant, Newbo | 2022 |
Drug resistance characteristics and molecular typing of Escherichia coli isolates from neonates in class A tertiary hospitals: A multicentre study across China.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; Carbapenems; Cefotaxime; Child; Ciprofloxacin; Do | 2022 |
Clinical and cost-effectiveness analysis of carbapenems versus ciprofloxacin in the treatment of urinary tract infections due to extended spectrum β-lactamase-producing Enterobacterales.
Topics: Adult; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Cost-Effectiveness Analys | 2023 |
Fluoroquinolone exposure in utero did not affect articular cartilage of resulting foals.
Topics: Animals; Anti-Bacterial Agents; Cartilage, Articular; Ciprofloxacin; Enrofloxacin; Female; Fluoroqui | 2021 |
Maternal antibiotic administration during a critical developmental window has enduring neurobehavioural effects in offspring mice.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anxiety; Ciprofloxacin; Cognition; Female; Homing Behavi | 2021 |
Therapeutic concentration of ciprofloxacin and transfer across the human term placenta.
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Female; Humans; Models, Biological; Placenta; Pregnancy | 2021 |
Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure.
Topics: Administration, Oral; Adult; Birth Rate; Chronic Disease; Ciprofloxacin; Endometritis; Female; Human | 2017 |
Effects of ciprofloxacin on fetal rat liver during pregnancy and protective effects of quercetin.
Topics: Animals; Ciprofloxacin; Female; Female Urogenital Diseases; Liver; Pregnancy; Quercetin; Rats; Rats, | 2017 |
Non-tuberculous mycobacterium bacteraemia in a pregnant systemic lupus erythematosus (SLE) patient: a case review and pooled case analysis.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ciprofloxacin; Clarithromycin; Female; Humans; Lupus Eryth | 2018 |
Effects of ciprofloxacin and quercetin on fetal brain development: a biochemical and histopathological study.
Topics: Animals; Anti-Bacterial Agents; Antioxidants; Brain; Brain Diseases; Catalase; Ciprofloxacin; Drug E | 2019 |
Unilateral acute dacryocystitis associated with oculoglandular tularemia: a case report.
Topics: Acute Disease; Adult; Amikacin; Anti-Bacterial Agents; Antibodies, Bacterial; Ciprofloxacin; Clavula | 2013 |
Chryseobacterium gleum - a novel bacterium species detected in neonatal respiratory tract infections.
Topics: Chryseobacterium; Ciprofloxacin; Cross Infection; Female; Flavobacteriaceae Infections; Humans; Infa | 2014 |
Effects of antibiotic treatment on the lactobacillus composition of vaginal microbiota.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Erythromycin; Female; Gentamicins; Humans; Lactob | 2015 |
The Rise of Fluoroquinolone-Resistant Escherichia coli in the Community: Scarier Than We Thought.
Topics: Anti-Bacterial Agents; Carrier State; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; E | 2015 |
Gut Colonization of Healthy Children and Their Mothers With Pathogenic Ciprofloxacin-Resistant Escherichia coli.
Topics: Adult; Anti-Bacterial Agents; Carrier State; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacte | 2015 |
Genital carriage of the genus Haemophilus in pregnancy: species distribution and antibiotic susceptibility.
Topics: Adolescent; Adult; Ampicillin; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Dru | 2015 |
Pregnancy - associated human listeriosis: Virulence and genotypic analysis of Listeria monocytogenes from clinical samples.
Topics: Animals; Ciprofloxacin; DNA Fingerprinting; Female; Genotype; Humans; Listeria monocytogenes; Lister | 2015 |
Characteristics of bacterial acute diarrhea among women.
Topics: Adolescent; Adult; Ampicillin; Anti-Bacterial Agents; Brazil; Ceftriaxone; Ciprofloxacin; Cross-Sect | 2016 |
Notes from the Field: Expanded Chemoprophylaxis Offered in Response to a Case of Meningococcal Meningitis in an Elementary School - Indiana, 2015.
Topics: Adult; Child; Ciprofloxacin; Contact Tracing; Female; Humans; Indiana; Male; Meningitis, Meningococc | 2016 |
Notes from the Field: Compliance with Postexposure Prophylaxis for Exposure to Bacillus anthracis Among U.S. Military Personnel - South Korea, May 2015.
Topics: Amoxicillin; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Bacillus anthracis; Ciprofloxacin; Co | 2017 |
Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India.
Topics: Ciprofloxacin; Cross Infection; Drug Resistance, Bacterial; Enterococcus; Female; Fluoroquinolones; | 2016 |
Neisseria gonorrhoeae meningitis in pregnant adolescent.
Topics: Adolescent; Anti-Bacterial Agents; Base Sequence; Ciprofloxacin; DNA Primers; Drug Resistance, Multi | 2008 |
Efficacy of ciprofloxacin in an experimental model of Escherichia coli chorioamnionitis in rabbits.
Topics: Animals; Anti-Infective Agents; Chorioamnionitis; Ciprofloxacin; Escherichia coli Infections; Female | 2009 |
Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations.
Topics: Abnormalities, Drug-Induced; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bioterrorism; Ciprofl | 2009 |
High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Mu | 2008 |
Change of antimicrobial susceptibility among Escherichia coli strains isolated from female patients with community-onset acute pyelonephritis.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Ciprofloxacin; Community-Acquired Infections; Dru | 2012 |
Management of asymptomatic pregnant or lactating women exposed to anthrax.
Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bacterial; Bacillus anthracis; Bi | 2002 |
Developmental toxicity studies of the quinolone antibacterial agent irloxacin in rats and rabbits.
Topics: Abnormalities, Drug-Induced; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Embry | 2003 |
Effects of ciprofloxacin on foetal hepatocytes.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Female; Fetus; Hepatocytes; Pregnancy; Rats; Rats, Wi | 2003 |
Gentamicin use in pregnancy. A renal anomaly.
Topics: Abnormalities, Drug-Induced; Adult; Anti-Infective Agents; Ciprofloxacin; Drug Therapy, Combination; | 2004 |
[Ulcerative colitis. Chronic active course].
Topics: Administration, Oral; Adult; Age Factors; Anti-Infective Agents; Azathioprine; Child; Chronic Diseas | 2004 |
Transfer of ciprofloxacin, ofloxacin and levofloxacin across the perfused human placenta in vitro.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Fetus; Fluoroquinolones; Humans; In Vitro Techniques; | 2005 |
Reproductive performance of pregnant rats and embryotoxic effects of ciprofloxacin.
Topics: Animals; Anti-Bacterial Agents; Bone Development; Ciprofloxacin; Embryo Implantation; Embryo, Mammal | 2006 |
Cytotoxic effect of ciprofloxacin in primary culture of rat astrocytes and protection by Vitamin E.
Topics: Animals; Anti-Infective Agents; Antioxidants; Astrocytes; Catalase; Cell Culture Techniques; Cell Pr | 2007 |
Efficacy of difloxacin for the control of postpartum uterine infections of ewes.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Case-Control Studies; Ciprofloxacin; Escheri | 2007 |
Two unusual glandular presentations of tick-borne tularemia.
Topics: Animals; Bites and Stings; Ciprofloxacin; Combined Modality Therapy; Contraindications; Doxycycline; | 2008 |
Ciprofloxacin for multiresistant enteric fever in pregnancy.
Topics: Adult; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Female; Humans; India; | 1995 |
Treatment of typhoid in pregnancy.
Topics: Adolescent; Adult; Asia, Western; Child; Ciprofloxacin; Drug Resistance, Multiple; Female; Humans; M | 1995 |
Placental transfer of enrofloxacin and ciprofloxacin in rabbits.
Topics: Animals; Anti-Infective Agents; Blood Proteins; Ciprofloxacin; Enrofloxacin; Female; Fluoroquinolone | 1994 |
Infectious osteitis pubis in an HIV seropositive female.
Topics: Abortion, Induced; Ciprofloxacin; Female; HIV Seropositivity; Humans; Osteitis; Pregnancy; Pregnancy | 1994 |
Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
Topics: Administration, Oral; Animals; Anti-Infective Agents; Ciprofloxacin; Embryo, Mammalian; Female; Fler | 1993 |
Chloramphenicol resistant enteric fever.
Topics: Adolescent; Adult; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Female; Gentamicins; | 1993 |
Quinolone-induced arthropathy in the neonatal mouse. Morphological analysis of articular lesions produced by pipemidic acid and ciprofloxacin.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Body Weight; Cartilage, Articular; Ciprofloxacin; | 1995 |
Use of the new quinolones during pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Infective Agents; Child, Preschool; Ciprofloxacin; Female; Follow- | 1996 |
Penetration of enrofloxacin and ciprofloxacin into breast milk, and pharmacokinetics of the drugs in lactating rabbits and neonatal offspring.
Topics: Animals; Animals, Newborn; Anti-Infective Agents; Chromatography, High Pressure Liquid; Ciprofloxaci | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxac | 1996 |
Isolation and antimicrobial susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows with retained fetal membranes and postparturient endometritis.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Cattle; Cattle Diseases; Ciprofloxacin; Clindam | 1996 |
Q fever in pregnancy.
Topics: Adult; Anti-Infective Agents; Cesarean Section; Ciprofloxacin; Female; Humans; Infection Control; In | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; | 1997 |
Ciprofloxacin immunomodulation of experimental antiphospholipid syndrome associated with elevation of interleukin-3 and granulocyte-macrophage colony-stimulating factor expression.
Topics: Adjuvants, Immunologic; Animals; Anti-Infective Agents; Antibody Formation; Antiphospholipid Syndrom | 1998 |
[Breast abscess and pregnancy toxemia revealing multidrug resistant tuberculosis].
Topics: Abscess; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Breas | 1999 |
National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Contraindications; Doxycycline; Female; Genital | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contrain | 1999 |
National guideline for the management of pelvic infection and perihepatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Cefoxitin; Ceftriaxone; Ciprofloxacin; Clindamycin; Contact Tracing; Female; | 1999 |
Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
Topics: Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; B | 2001 |
From the Centers for Disease Control and Prevention. Updated recommendations for antimicrobial prophylaxis among asymptomatic pregnant women after exposure to Bacillus anthracis.
Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
Post-exposure anthrax prophylaxis.
Topics: Amoxicillin; Animals; Anthrax; Anthrax Vaccines; Anti-Bacterial Agents; Anti-Infective Agents; Child | 2001 |
Advice for travelers.
Topics: Africa; Altitude Sickness; Asia; Chloroquine; Ciprofloxacin; Contraindications; Diarrhea; Female; He | 2002 |
Ciprofloxacin: toxicologic evaluation of additional safety data.
Topics: Abortion, Spontaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain; Ciprofloxacin; Dogs; | 1989 |
Pharmacokinetics of three newer quinolones in pregnant and lactating women.
Topics: Adult; Ciprofloxacin; Female; Humans; Lactation; Maternal-Fetal Exchange; Milk, Human; Ofloxacin; Pe | 1989 |
Ciprofloxacin-induced interstitial nephritis.
Topics: Adult; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Klebsiella Infections; Klebsiella pneum | 1989 |
Pharmacokinetics of ciprofloxacin. 2nd communication: distribution to and elimination from tissues and organs following single or repeated administration of [14C]ciprofloxacin in albino rats.
Topics: Administration, Oral; Animals; Autoradiography; Body Burden; Carbon Radioisotopes; Ciprofloxacin; Do | 1986 |
Pharmacokinetics of ciprofloxacin. 1st communication: absorption, concentrations in plasma, metabolism and excretion after a single administration of [14C]ciprofloxacin in albino rats and rhesus monkeys.
Topics: Administration, Oral; Animals; Body Burden; Carbon Radioisotopes; Ciprofloxacin; Duodenum; Feces; Fe | 1986 |